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Abstract
C. albicans triggers recurrent infections of the alimentary tract mucosa that result from biofilm growth. Although the ability
of C. albicans to form a biofilm on abiotic surfaces has been well documented in recent years, no information exists on
biofilms that form directly on mucosal surfaces. The objectives of this study were to characterize the structure and
composition of Candida biofilms forming on the oral mucosa. We found that oral Candida biofilms consist of yeast, hyphae,
and commensal bacteria, with keratin dispersed in the intercellular spaces. Neutrophils migrate through the oral mucosa
and form nests within the biofilm mass. The cell wall polysaccharide b-glucan is exposed during mucosal biofilm growth and
is more uniformly present on the surface of biofilm organisms invading the oral mucosa. We conclude that C. albicans forms
complex mucosal biofilms consisting of both commensal bacterial flora and host components. These discoveries are
important since they can prompt a shift of focus for current research in investigating the role of Candida-bacterial
interactions in the pathogenesis of mucosal infections as well as the role of b-glucan mediated signaling in the host
response.
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Introduction
Biofilms are well organized microbial communities adhering
to an inanimate or living tissue surface [1]. The term mucosal
biofilm further denotes a sessile form of microbial growth on
mucosal surfaces which can trigger chronic or recurrent
infections, usually devoid of cultivable microbes in tissue
exudates [2,3]. C. albicans is a commensal colonizer of mucous
membranes that can become an opportunistic pathogen, causing
common mucosal infections as well as life threatening invasive
infections in immunosuppressed patients [4]. It has been
hypothesized that biofilm growth of this organism on mucosal
surfaces is responsible for the white plaque oral lesions, which
are highly diagnostic of pseudomembranous candidiasis [5].
However, its ability to form well organized biofilm communities
on oral mucosal tissues has not been documented before.
Furthermore, since the oral cavity harbors a vast range of
bacterial species [6] it is likely that C. albicans interacts closely
with the resident bacterial flora during mucosal biofilm
formation. However, bacterial-Candida co-existence within the
o r a lw h i t ep l a q u e si nh u m a n so ra n i m a l sh a sn e v e rb e e n
demonstrated in situ.
Biofilm cells possess distinct phenotypic characteristics com-
pared to their planktonic counterparts [7]. C. albicans biofilms
have been shown to have altered composition of their carbohy-
drate cell walls with an increase in the total content of b-glucans
[8]. Polysaccharides such as b-glucans constitute 50–60% of C.
albicans cell wall and are usually ‘‘masked’’ by a layer of mannan
during planktonic in vitro growth [9]. Recent studies, however,
have suggested that b-glucans may become ‘‘unmasked’’ during
infection in vivo thus allowing dectin-1 recognition and immune
activation [10]. Whether b-glucan exposure is associated with a
biofilm phenotype or its exposure on the surface of C. albicans
occurs as a result of the in vivo environment has not been
resolved.
There is universal agreement among microbiologists that the
study of biofilms is far more difficult than the study of planktonic
organisms. In addition to technical challenges associated with the
study of abiotic surface biofilms, the study of tissue biofilms is
further complicated by the poor accessibility to human tissue
samples and/or the lack of faithful animal models of infection.
The establishment of adequate models of mucosal biofilm
infections is therefore the first step in understanding the
mechanisms of biofilm formation on tissue surfaces. In this
work, we employed a mouse model of oropharyngeal candidiasis,
in which the white plaque lesions were faithfully reproduced, to
systematically characterize the composition of mucosal biofilms
in situ. In some instances the animal work was complemented
with experiments using a three-dimensional in vitro model of the
human oral mucosa, developed in our laboratory [11,12].
In this study we hypothesize that C. albicans forms complex
oral mucosal biofilms involving both bacterial and host
components. We provide direct evidence for the first time
that epithelial cells, neutrophils and commensal oral bacteria
co-exist with C. albicans in mucosal biofilms. Furthermore, we
demonstrate that b-glucan is present on the fungal cell surface
not only during mucosal biofilm development but also during
in vitro biofilm growth.
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Three-Dimensional Structure of Mucosal Biofilms
In order to visualize live, fully hydrated biofilms in vivo we
infected mice with a GFP-expressing strain of C. albicans and
examined the white plaques formed on the dorsal surface of the
tongue by confocal microscopy (Fig. 1A,B). Confocal imaging
followed by 3D reconstruction of live tongue biofilms revealed an
architecture that followed the epithelial microanatomical varia-
tions of the lingual papillae, forming ‘‘valleys’’ and higher
‘‘elevations’’ of stacking fungal cells (Fig. 1C). We also observed
abundant dark areas inter-dispersed among fluorescent organisms,
suggestive of extracellular matrix (Fig. 1C).
Beta-Glucan Distribution in Mucosal Biofilms
Since the total content of b-glucans increases in abiotic surface
Candida biofilms [8] we decided to characterize its distribution
pattern in oral mucosal biofilms. To detect b-glucan we used a
monoclonal antibody highly specific for (1R6) branched, (1R3)-b-
D-glucans (BFDiv, Biothera) found on fungal cell walls, which does
not recognize linear, essentially homogeneous glucans [13]. The
specificity of this antibody to C. albicans cell wall glucans has been
confirmed in other studies [14]. In tissue sections of tongue
biofilms b-glucan was immunoaccessible throughout the biofilm
mass and its presence was noted on the surface of both yeast and
hyphal organisms (Fig. 2A–D). However, the distribution of b-
glucan became more uniform on the surface of fungal cells
invading the tongue mucosa (Fig. 2C,D). Absence of fluorescent
signal in control stains without primary antibody showed that no
detectable mouse host IgM was bound to organisms invading the
tongue mucosa (not shown). In addition to this control, the
specificity of our staining protocol was tested by using a mouse
isotype control (IgM) antibody (Fig. 2E).
It has been hypothesized that b-glucan is ‘‘unmasked’’ during
the course of infection in vivo due to progressive damage of fungal
cells by immune cell attacks [10]. In order to address this
possibility, we examined the distribution of b-glucan in mucosal
biofilms growing on our three-dimensional in vitro model of the
human oral mucosa, which is devoid of an immune cell
component [12]. These air-lifted, semi-dry cultures receive media
from the basal surface only, thus fungal growth is directed basally,
toward the tissue where nutrients are more readily available. As
seen in Fig. 2F b-glucan was more abundant in the basal two thirds
of the biofilm mass (closer to the tissue surface) and was more
uniformly displayed on the surface of the majority of hyphal cells
invading into the submucosal compartment. Thus, b-glucan was
displayed on the fungal cell surface in the absence of immune cells.
To ascertain whether b-glucan is on the surface of biofilm
cells only when growing within a mucosal tissue environment
we examined its cellular distribution on abiotic (glass) surface
biofilms during different stages of growth. The entire
extracellular matrix was visualized with ConA-Alexa 350
(blue, for GFP-expressing strain, figure 3) or ConA-Alexa
488 (green, for strain SC5314, figure 4) and the b-glucan
component was visualized using the monoclonal antibody
BFDiv, followed by a Cy-3-conjugated secondary antibody
(red). This double staining was used to decipher whether the
entire or part of the ECM consisted of b-glucan. In early
biofilms BFDiv stained parts of the fungal cell, but not the
germinating buds, whereas ConA stained the entire fungal cell
surface, including the bud (Fig. 3A). Partial co-localization was
seen between ConA and BFDiv staining, during early biofilm
growth (Fig. 3A, pink). In later stages of biofilm growth,
deposits of cell-dissociated ECM stained with ConA (blue) but
not BFDiv (Fig 3B, arrows), suggesting that either: a) b-glucan
is not present in this diffuse extracellular material; or b)
Figure 1. C. albicans presence in ‘‘white plaque’’ lesions formed on the tongue of mice with oropharyngeal candidiasis. C. albicans-
challenged mice were sacrificed after 5 days of oral exposure to the GFP-expressing strain MRL51. Panel A depicts the dorsal aspect of a tongue from
an uninfected control. Panel B depicts the white plaque lesions formed on the tongue of an infected mouse. Panel C depicts a three dimensional
reconstruction of a live biofilm as visualized via confocal microscopy.
doi:10.1371/journal.pone.0007967.g001
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heterogeneous type of beta glucans recognized by this
antibody. Interestingly, in biofilms forming on glass, the cell-
wall associated b-glucan was uniformly present at the
elongating, unattached end of the biofilm, regardless of biofilm
thickness or stage of development (Fig. 4A–C). The striking
similarity in the pattern of b-glucan staining in biofilms of
variable thickness (30–140 mm, Fig 4A–C) also illustrates that
this is not an artifact due to reduced efficiency of penetration
of the fluorescent reagent and/or antibody into the biofilm
mass. Taken together these observations suggest that b-glucan
display on the fungal cell wall during biofilm growth is not
specific to tissue biofilms but occurs primarily at the advancing
or extending end of biofilms, both in vitro and in vivo.
Figure 2. Display of b-glucan during different stages of C. albicans mucosal biofilm growth. Panels depict representative confocal images
of tissue sections from mice with oropharyngeal candidiasis (A–D) or from a three-dimensional in vitro model of the oral mucosa (F). Panels A–D and F
depict sections stained for b-glucan with a BFDiv monoclonal antibody (red), C. albicans with a polyclonal anti-Candida Ab (green) and counterstained
with the nucleic acid stain TO-PRO-3, which stains tissue cells blue. Panel E depicts a section stained with an IgM isotype control antibody for the
BFDiv stain. Notice that b-glucan becomes more uniformly present on the surface of fungal cells invading the tongue mucosa (arrows). Scale
bar=20 mm.
doi:10.1371/journal.pone.0007967.g002
Figure 3. b-glucan and extracellular material staining in C. albicans biofilms forming on glass. Panel A depicts a 2h biofilm and panel B
depicts a 48h biofilm. Biofilms of the GFP-expressing C. albicans strain (green) were stained for b-glucan with a BFDiv monoclonal antibody (red) and
the extracellular material was stained with ConA-Alexa 350 (blue). In 2h biofilms there is partial co-localization of the BFDiv mAb and ConA (pink).
BFDiv stains parts of the fungal cell, but not the germinating buds, and ConA stains the entire fungal cell surface (3A). In 48h biofilms deposits of cell-
dissociated ECM stained with ConA but not with BFDiv (3B, arrows). Scale bar=20 mm.
doi:10.1371/journal.pone.0007967.g003
C. albicans Mucosal Biofilms
PLoS ONE | www.plosone.org 3 November 2009 | Volume 4 | Issue 11 | e7967Contribution of Host Cell Components in Mucosal Biofilm
Structure
Since Candida infection triggers a hyperkeratotic response in oral
epithelium [15], we hypothesized that keratin originating from
desquamating epithelial cells is incorporated in the biofilm mass.
We found that a significant proportion of the extracellular material
in mouse tongue Candida biofilms consisted of keratin associated
with desquamating epithelial cells (Fig. 5A). In fact Candida was
frequently surrounded by keratin squames, which comprised part
of the extracellular matrix (Fig. 5B–C, arrows).
A prominent feature of infections characterized by a soft tissue
biofilm is infiltration of infected tissues by neutrophils [16,17].
Apart from conferring protection at mucosal sites, neutrophils may
also become part of the biofilm mass, and their products may serve
as a matrix to enhance biofilm formation [18]. We thus
hypothesized that neutrophils form part of the biofilm mass on
the surface of the tongue in infected animals. To examine the
presence of these cells, 3-color CLSM was used to visualize the
fungal organisms, epithelial cells and neutrophils. We found that
neutrophils formed aggregates juxtaposed to mucosal biofilms
(Fig. 6A–C). In sites with thicker biofilms, neutrophils migrated
through the entire width of the mucosa, with neutrophil ‘‘nests’’
forming within the biofilm mass (Fig. 6C). No neutrophil
aggregates were observed in uninfected animal tissues (not shown).
Contribution of Oral Bacterial Flora in Candida Mucosal
Biofilms
Finally, we hypothesized that mucosal fungal biofilms constitute
polymicrobial communities containing bacterial species of the
resident oral flora. The mouse oral bacterial flora contains about
20 bacterial species which could theoretically contribute to biofilm
formation [19]. The most predominant species are Lactobacillus
murinus, Staphylococcus sp. and Enterococcus faecalis [19]. We thus
developed an immuno-fluorescence in situ hybridization (immuno-
FISH) labeling approach to simultaneously visualize C. albicans and
bacterial commensals in tongue biofilms of mice with oropharyn-
geal candidiasis. We observed that bacteria were present together
with C. albicans forming mixed mucosal biofilms as evidenced by
positive staining with Syto 59 (Fig. 7A,B) and the all bacteria-
specific probe EUB338 (Fig. 7C). Some bacteria were further
identified as Enterococcus/Lactobacillus sp. (Fig. 8A–C) and Staphylo-
coccus sp (Fig. 8D–E) using more specific probes. Tissues from 5
mice stained by this approach were positive for both bacteria and
C. albicans. Interestingly, mice positive for Staphylococcus sp. (4 out of
5) were not positive for Enterococcus/Lactobacillus sp. and a single
mouse positive for Enterococcus/Lactobacillus sp. did not give a
positive signal with the Staphylococcus sp. probe. It was also observed
that most of the bacteria were associated with the apical (not
tissue-associated) end of the biofilm, but some bacteria were also
seen to invade the tongue epithelium together with C. albicans.
Using this staining technique we could not identify commensal
bacteria adhering to the tongue surface in uninfected animals (not
shown), suggesting that C. albicans may promote tissue colonization
and invasion by normally ‘‘innocent’’ commensals.
Discussion
In this study for the first time we systematically characterized
the structure and composition of biofilms of C. albicans growing on
the oral mucosa. A similar form of superficial growth and
multicellular assembly of C. albicans has been previously reported
to take place on the stratified squamous epithelium of human
ectocervix organ cultures [20]. We conclude that oral mucosal
biofilms associated with C. albicans infection consist of complex
structures containing fungal, bacterial and host cells or cell-derived
products.
Abundant glucans can be extracted from the extracellular
material of Candida biofilms [21] and a glucan-cross-linked
protein has been shown to be critical in biofilm development
[22], therefore it was not surprising that b-glucan was readily
identifiable within mucosal biofilms. The prominent staining
pattern of b-glucan in cells invading the oral mucosa was
consistent with that seen on C. albicans cells invading the kidneys
of systemically infected rats or mice [10,14]. Cell surface
localization of b-glucan in vivo was not morphotype-specific,
again consistent with recent studies in systemically infected mice,
in which a different anti- b-glucan monoclonal antibody was used
[10]. However in our studies, the b-glucan staining pattern was
similar in vitro and in vivo, since it was primarily localized at the
active site of biofilm growth, which indicates that it may be a
Figure 4. b-glucan and extracellular material staining during C.
albicans SC5314 in vitro biofilm growth on glass. Panels depict 3D
reconstructions of confocal stacks of images of 24h (A), 48h (B) and 72h
(C) biofilms of C. albicans grown on cover slips and stained for b-glucan
with BFDiv mAb (red) and ConA-Alexa 488 (green). Notice that
regardless of biofilm thickness b-glucan is localized in the growing
end of the biofilm (arrows).
doi:10.1371/journal.pone.0007967.g004
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not a result of exposure to the in vivo environment as it was
previously suggested [10]. Since b-glucan plays a role in the
immune recognition of Candida [23,24] and neutrophils are
clustered both adjacent and within the biofilm mass, access to cell
wall b-glucan may play an important role in their activation via
dectin-1-mediated signaling [14,25]. Therefore the functional
role of this receptor-ligand interaction in the context of mucosal
or catheter-associated biofilm infections needs to be further
investigated.
T h e s es t u d i e sf o rt h ef i r s tt i m es h e dl i g h to nt h ec o m p l e x i t yo f
oral mucosal biofilms formed by C. albicans.O u rf i n d i n g s
support the idea that the composition of mucosal biofilms is
inherently more complex than abiotic surface biofilms [18,26]
since host cells and the resident bacterial flora form part of the
biofilm mass. The identification of bacteria within the biofilm
mass in situ was not unexpected since bacteria are often co-
isolated with Candida from ulcerative lesions of the oral mucosa
in humans [27]. However for the first time we provide direct
evidence for complex polymicrobial communities in pseudo-
membranous lesions using an experimental model of Candida
infection. The relative contribution of these communities to the
pathogenesis of these lesions is unknown, with one report
suggesting bacterial involvement [28]. Thus novel hypotheses
can arise from our discovery-driven work, one of the most
intriguing being the potential synergistic relationship between C.
albicans and the oral bacterial flora, since bacterial adhesion and
invasion of the tongue mucosa was noted only in the C. albicans-
infected animals. Although antagonistic relationships between C.
albicans and prokaryotes have been described [29,30,31], little is
known about potential mechanisms of enhancement of bacterial
virulence by C. albicans [32].
In conclusion, our studies provide valuable new insights that will
lead to novel hypothesis-driven research that will further the
understanding of mucosal biofilm infections.
Methods
Ethics Statement
The study was approved by the University of Connecticut
Health Center Animal Care Committee. Animals were monitored
daily for distress. Given that the oral cavity is readily accessible,
lesions are detected relatively early in their onset and animals are
euthanized after lesion formation before visible distress/behavior
signs are observed.
Organisms
Strain SC5314, which was originally isolated from a patient
with invasive disseminated candidiasis [33], and displays a virulent
phenotype in several oral mucosal models [11,34], was used to
study in vivo and in vitro biofilm growth. A GFP tagged strain
(MRL51), derived from strain SC5314 was generously supplied by
Dr. A. Mitchell (Carnegie Mellon University) and used for live
biofilm visualization. The strains used in this study showed similar
growth rates in YPD liquid medium, as determined by direct cell
counts of yeast cells, or by the XTT assay [35]. The organisms
Figure 5. Cytokeratin presence in C. albicans biofilms formed on the tongue of mice with oropharyngeal candidiasis. Tissue sections in
panels A, B and C were stained with anti-cytokeratin mAb (red) and anti-Candida pAb (green). Host cell nuclei were visualized with TO-PRO-3 (blue).
Panel D represents an isotype control (IgG) stain. Arrows indicate areas where fungal cells are surrounded by keratin. Scale bar=20 mm.
doi:10.1371/journal.pone.0007967.g005
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MI) at 25uC overnight, then washed in PBS and counted in a
hemacytometer.
Mouse Model of Oropharyngeal Candidiasis
A mouse model of pseudomembranous oral candidiasis was
used in order to characterize mucosal biofilms in vivo. In these
experiments 6–8 week old female C57BL/6 mice were infected
with strain SC5314 or its GFP-tagged derivative (5 mice per
group). One day prior to infection mice were immunosuppressed
by subcutaneous injection with cortisone acetate (225 mg/kg)
dissolved in 200 ml PBS containing 0.5% Tween-20. To deliver C.
albicans challenge mice were anaesthetized by an intramuscular
injection of ketamine: xylazine (90–100 mg/kg and 10 mg/kg of
body weight, respectively) and a small cotton pad soaked with
100 mlo fC. albicans cell suspension (6610
8 yeast/ml) was used to
Figure 6. Neutrophils form aggregates in tongue biofilms of C.albicans-infected mice. Panels A–D depict tissue sections stained with an
anti-mouse neutrophil mAb (red), an anti-Candida Ab (green) and the nucleic acid stain TO-PRO-3 (blue). Panel E depicts a confocal image of a
negative control stain (primary anti-neutrophil mAb was omitted). Arrows indicate the presence of neutrophils directly juxtaposed to, or within the
biofilm mass. Scale bar=20 mm.
doi:10.1371/journal.pone.0007967.g006
Figure 7. Presence of bacteria in mucosal biofilms of mice with oropharyngeal candidiasis. Panels A and B depict tissue sections stained
with an anti-Candida pAb (green) and the nucleic acid stain Syto59 (red). Panel B is a 3.56zoom image of the marked area in Panel A. Notice the close
association of C. albicans and bacterial cells (arrows). Panel C depicts a tissue section stained with an anti-Candida antibody (green), processed for
fluorescence in situ hybridization (FISH) with the all bacteria-specific oligonucleotide probe EUB388 (red) and counterstained with the nucleic acid
stain Hoechst 33258 (blue). Notice the presence of bacteria (pink) throughout the mucosal biofilms (arrows). Scale bar=20 mm.
doi:10.1371/journal.pone.0007967.g007
C. albicans Mucosal Biofilms
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tongue and was removed before the animals awoke. This
procedure was repeated 2 days later and mice were sacrificed
after 5 days of total exposure to C. albicans. During this time period
animals were also given drinking water containing a daily-fresh
suspension of C. albicans (6610
6 yeast organisms/ml) to maintain
high oral carriage loads throughout the experimental period, since
oral carriage is one of the most frequently identified risk factors of
human oral infection [36,37]. At the end of each infection period,
tongues were dissected, formalin-fixed and embedded in paraffin.
Five mm sections were stained for immunofluorescence and
visualized by laser confocal scanning microscopy (LCSM). To
observed live, hydrated mucosal biofilms produced by the GFP-
expressing strain, unfixed intact pieces of tongues with biofilms
were mounted on glass-bottom Petri dishes (MatTek Corp.;
Ashland, MA) in PBS-2% glucose and examined in an inverted
confocal microscope.
Three-Dimensional Model of the Human Oral Mucosa
To investigate in vitro mucosal biofilm formation by C. albicans
we used a three-dimensional model of the oral mucosa as
previously described [12]. This system is composed of 3T3
fibroblasts embedded in a biomatrix of collagen type I, overlaid by
a multilayer of well-differentiated oral epithelial cells (OKF6/
TERT-1). C. albicans cells (1610
6 yeast cells) were added to the
cultures apically in 100ml of airlift medium [12] without FBS and
antibiotics. After 24–48 hours of co-culture infected mucosal
tissues were formalin-fixed and embedded in paraffin. Five mm
sections were stained by immunofluorescence and visualized by
LCSM.
Abiotic Surface Biofilms
For growth of biofilms on abiotic surfaces yeast cells of strain
SC5314 or its GFP-tagged derivative were seeded on FBS-coated
glass cover slips in 12 well plates at a density of 1610
7 cells/well.
After growth in YNB medium containing 0.5% glucose at 37uC for
2–48 hours, they were stained with anti b-glucan monoclonal
antibody (as described below) and ConA conjugated with Alexa
Fluor 488 (for strain strain SC5314) or Alexa Fluor 350 (for GFP-
expressing strain, both dyes at 40 mg/ml, Invitrogen, Carsbad,
CA). Cover slips were mounted on slides or glass bottom dishes,
and biofilms were observed with a Zeiss LSM 510 NLO/FSM
microscope. Z-sections were collected and reconstructed into 3D
images using the IMARIS software (Bitplane, Inc., Saint Paul,
MN).
Immunofluorescence
Tissue sections from formalin-fixed paraffin-embedded samples
were incubated for 1 hour with monoclonal antibodies against b-
glucan (22 mg/ml, clone 10C6, Biothera, Eagan, MN), monoclo-
nal anti-pan cytokeratin (1.2 mg/ml, clone AE1/AE3, Dako), or
anti-neutrophil monoclonal antibody (1 mg/ml, clone NIMP-R14,
Santa Cruz Biotechnology, Santa Cruz, CA). For cytokeratin and
neutrophil staining, antigen retrieval was performed by heating
sections at 96uC for 30 minutes with Target Retrieval Solution
(DakoCytomation, Carpinteria, CA) prior to incubation with
Figure 8. Identification of specific components of bacterial commensal flora in mucosal biofilms of mice with oropharyngeal
candidiasis. Panels A-C depict a tongue tissue section stained with an anti-Candida antibody (green) and processed for fluorescence in situ
hybridization (FISH) with the all bacteria-specific oligonucleotide probe EUB388 (blue) and the Lactobacillus and Enterococcus sp.-specific probe
LAB158 (red). Panels B and C are a 3.56zoom image of the marked areas in Panel A. Bacteria positive with the LAB158 probe appear pink due to co-
localization with the all bacteria specific probe EUB338 (arrows). Panels D and F depict a tongue tissue section stained with an anti-Candida antibody
(green) and processed for FISH with the all bacteria-specific probe EUB388 (blue) and the Staphylococcus sp.-specific probe STA697 (red). Panels E and
F are a 3.56zoom image of the marked areas in Panel D. Bacteria positive with the STA697 probe appear pink due to co-localization with the EUB338
probe (arrows). Scale bar=20 mm.
doi:10.1371/journal.pone.0007967.g008
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with the appropriate Cy-3-conjugated secondary antibody (goat
F(ab)92 anti-mouse IgM, goat anti-mouse IgG, or Goat anti-Rat
IgG, respectively, all from Jackson Immunoresearch, West Grove,
PA) and FITC-conjugated rabbit anti-Candida polyclonal antibody
(40 mg/ml, Meridian Life Science, Cincinnati, OH). Blocking and
staining for cytokeratin was done using the MOM system (Vector;
Burlingame, CA). Lastly, TO-PRO-3 staining of cell nuclei was
performed (2mM, Invitrogen, Carsbad, CA) for 30 minutes in
some samples. Stained sections were examined with a Zeiss LSM
510 NLO/FSM confocal scanning laser microscope (Carl Zeiss
Microimaging, Inc.; Thornwood, NY) equipped with argon
(488nm) and HeNe (543nm and 633nm) lasers, using a water
immersion C-Apochromat 406objective (NA1.2).
Fluorescence In Situ Hybridization
Formalin-fixed tissue sections were deparaffinized and stained
for 1 h with a FITC-labeled anti-Candida polyclonal antibody
(Meridian Life Science, Cincinnati, OH). Slides were then washed
with PBS and permeabilized with lysozyme (70,000 U/mL in
100 mM Tris/HCl pH 7.5, 5 mM EDTA) for 10 min at 37uCi n
a humid atmosphere. Samples were then dehydrated in a series of
ethanol washes (50, 80 and 100% ethanol; 3 min each) and
exposed to 25 mL of hybridization buffer (0.9 M NaCl, 20 mM
Tris/HCl pH 7.5, 0.01% sodium dodecyl sulfate and 25%
formamide) containing 10 ng/mL of probe. Slides were incubated
at 46uC for 90 min in a humid atmosphere and washed for 15 min
at 48uC in washing buffer (20 mM Tris/HCl pH 7.5, 5 mM
EDTA, 0.01% sodium dodecyl sulfate and 159 mM NaCl). After
the immuno-FISH procedure some samples were counter-stained
with the nucleic acid stain Hoechst 33258 (Invitrogen, Carsbad,
CA). In samples where no FISH was performed, slides were
stained with anti-Candida antibody and the nucleic acid stain Syto
59 (Invitrogen). The oligonucleotide probes used were purchased
from Eurofins MWG/Operon and included the EUB338 probe
specific for bacteria [38] labeled with either Alexa 546 or Alexa
633, the LAB158 probe specific for Lactobacillus and Enterococcus sp.
[39] labeled with Alexa 546, and the STA697 probe specific for
Staphylococcus sp. [40] labeled with Alexa 546. The specificity and
efficiency of all probes at 25% formamide was first tested in vitro
with laboratory strains representing the target genera and
unrelated control species. All samples were observed with a 406
1.3 NA oil-immersible lens on a Zeiss LSM 510 NLO/FSM
confocal scanning laser microscope.
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